Gratus Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.19M Sell
9,246
-74
-0.8% -$8.66K 0.15% 52
2026
Q1
$1.12M Buy
9,320
+3
+0% +$346 0.16% 55
2025
Q4
$981K Sell
9,317
-1,121
-11% -$105K 0.14% 61
2025
Q3
$876K Sell
10,438
-525
-5% -$43.2K 0.12% 67
2025
Q2
$868K Sell
10,963
-6
-0.1% -$477 0.13% 65
2025
Q1
$985K Sell
10,969
-5,980
-35% -$558K 0.16% 57
2024
Q4
$1.69M Sell
16,949
-486
-3% -$50.1K 0.27% 35
2024
Q3
$1.89M Buy
17,435
+1,570
+10% +$187K 0.31% 37
2024
Q2
$2M Buy
15,865
+1,187
+8% +$153K 0.34% 35
2024
Q1
$1.84M Buy
14,678
+933
+7% +$115K 0.34% 35
2023
Q4
$1.5M Buy
+13,745
New +$1.43M 0.3% 41

Other funds holding MRK

Gratus Wealth Advisors's MRK Position: Q2 2026 in Review

Gratus Wealth Advisors reduced its Merck (MRK) stake by 0.79% in Q2 2026, selling an estimated $8.66K and leaving 9,246 shares worth $1.19M. The position accounts for 0.15% of the portfolio, ranked #52.

Gratus Wealth Advisors first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $2M in Q2 2024. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Gratus Wealth Advisors held 9,246 shares of Merck worth $1.19M as of Q2 2026.
  • Gratus Wealth Advisors sold 74 Merck shares in Q2 2026, an estimated $8.66K.
  • Merck made up 0.15% of Gratus Wealth Advisors's portfolio in Q2 2026, its #52 holding.
  • Gratus Wealth Advisors first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • Gratus Wealth Advisors's Merck position peaked at $2M in Q2 2024.
  • 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Gratus Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.